EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

European Association For The Study Of The Liver

MeSH — NLM indexing Antiviral Agents / therapeutic use Drug Monitoring / methods Europe Hepatitis B virus / drug effects Hepatitis B, Chronic / drug therapy Hepatitis B, Chronic / physiopathology Humans

Staff actions

Download PDF

Files are for authorised use within BioPredictive partner channels only.

Fibrotest Actitest Guideline Independent Group France

Authors (1)

European Association For The Study Of The Liver

Citation

European Association For The Study Of The Liver. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167-85. doi:10.1016/j.jhep.2012.02.010.

Identifiers

DOI: 10.1016/j.jhep.2012.02.010
PMID: 22436845

Tests

Liver diseases

Liver injuries

Comparisons

Subjects

Region

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection.

More on the same topic

Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference.

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.

Toward non-invasive assessment strategies in autoimmune hepatitis.

Accuracy of prognostic serological biomarkers in predicting liver fibrosis severity in people with metabolic dysfunction-associated steatotic liver disease: a meta-analysis of over 40,000 participants.

Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.

Novel Biomarkers of Grade I Left Ventricular Diastolic Dysfunction in Type 2 Diabetes Patients with Metabolic-Dysfunction-Associated Steatotic Liver Disease.